Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Clin Pediatr Endocrinol ; 33(2): 71-75, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38572381

RESUMO

A 10-yr-old female was referred due to prolonged bleeding lasting for a week following tooth extraction. She had heavy periods since she was 9. Her height was < 0.4th centile. Tanner staging was breast stage B3-4, axillary hair A1, and pubic hair P1. Thyroid function tests showed elevated TSH, low free T4, and negative anti-TPO antibodies. Gonadotrophins showed high FSH and a prepubertal LH. Prolactin was high and ovarian cysts were found on ultrasound. Further investigations revealed low von Willebrand factor (vWF) antigen levels, leading to a diagnosis of acquired von Willebrand disease. She was started on levothyroxine therapy, with normalization of vWF antigen levels, prolactin levels, cessation of her menstrual periods and resolution of ovarian cysts.

2.
Arch Endocrinol Metab ; 63(2): 113-120, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31038592

RESUMO

OBJECTIVE: There is controversy regarding cognitive function in patients with congenital adrenal hyperplasia (CAH). This study is aimed at the assessment of cognitive functions in children with CAH, and their relation to hydrocortisone (HC) therapy and testosterone levels. SUBJECTS AND METHODS: Thirty children with CAH due to 21 hydroxylase deficiency were compared with twenty age- and sex-matched healthy controls. HC daily and cumulative doses were calculated, the socioeconomic standard was assessed, and free testosterone was measured. Cognitive function assessment was performed using the Wechsler Intelligence Scale - Revised for Children and Adults (WISC), the Benton Visual Retention Test, and the Wisconsin Card Sorting Test (WCST). RESULTS: The mean age (SD) of patients was 10.22 (3.17) years [11 males (36.7%), 19 females (63.3%)]. Mean (SD) HC dose was 15.78 (4.36) mg/m 2 /day. Mean (SD) cumulative HC dose 44,689. 9 (26,892.02) mg. Patients had significantly lower scores in all domains of the WISC test, performed significantly worse in some components of the Benton Visual Retention Test, as well as in the Wisconsin Card Sorting Test. There was no significant difference in cognitive performance when patients were subdivided according to daily HC dose (< 10, 10 - 15, > 15 mg/m 2 /day). A positive correlation existed between cumulative HC dose and worse results of the Benton test. No correlation existed between free testosterone and any of the three tests. CONCLUSION: Patients with CAH are at risk of some cognitive impairment. Hydrocortisone therapy may be implicated. This study highlights the need to assess cognitive functions in CAH.


Assuntos
Hiperplasia Suprarrenal Congênita/psicologia , Anti-Inflamatórios/administração & dosagem , Cognição , Hidrocortisona/administração & dosagem , Adolescente , Hiperplasia Suprarrenal Congênita/sangue , Hiperplasia Suprarrenal Congênita/metabolismo , Anti-Inflamatórios/farmacologia , Estudos de Casos e Controles , Criança , Cognição/efeitos dos fármacos , Transtornos Cognitivos/diagnóstico , Relação Dose-Resposta a Droga , Feminino , Humanos , Hidrocortisona/farmacologia , Deficiência Intelectual/diagnóstico , Masculino , Testes Neuropsicológicos , Fatores Socioeconômicos , Testosterona/sangue , Percepção Visual/efeitos dos fármacos , Escalas de Wechsler
3.
Arch. endocrinol. metab. (Online) ; 63(2): 113-120, Mar.-Apr. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1001211

RESUMO

ABSTRACT Objective There is controversy regarding cognitive function in patients with congenital adrenal hyperplasia (CAH). This study is aimed at the assessment of cognitive functions in children with CAH, and their relation to hydrocortisone (HC) therapy and testosterone levels. Subjects and methods Thirty children with CAH due to 21 hydroxylase deficiency were compared with twenty age- and sex-matched healthy controls. HC daily and cumulative doses were calculated, the socioeconomic standard was assessed, and free testosterone was measured. Cognitive function assessment was performed using the Wechsler Intelligence Scale - Revised for Children and Adults (WISC), the Benton Visual Retention Test, and the Wisconsin Card Sorting Test (WCST). Results The mean age (SD) of patients was 10.22 (3.17) years [11 males (36.7%), 19 females (63.3%)]. Mean (SD) HC dose was 15.78 (4.36) mg/m 2 /day. Mean (SD) cumulative HC dose 44,689. 9 (26,892.02) mg. Patients had significantly lower scores in all domains of the WISC test, performed significantly worse in some components of the Benton Visual Retention Test, as well as in the Wisconsin Card Sorting Test. There was no significant difference in cognitive performance when patients were subdivided according to daily HC dose (< 10, 10 - 15, > 15 mg/m 2 /day). A positive correlation existed between cumulative HC dose and worse results of the Benton test. No correlation existed between free testosterone and any of the three tests. Conclusion Patients with CAH are at risk of some cognitive impairment. Hydrocortisone therapy may be implicated. This study highlights the need to assess cognitive functions in CAH.


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Hidrocortisona/administração & dosagem , Cognição/efeitos dos fármacos , Hiperplasia Suprarrenal Congênita/psicologia , Anti-Inflamatórios/administração & dosagem , Fatores Socioeconômicos , Testosterona/sangue , Percepção Visual/efeitos dos fármacos , Escalas de Wechsler , Hidrocortisona/farmacologia , Estudos de Casos e Controles , Transtornos Cognitivos/diagnóstico , Hiperplasia Suprarrenal Congênita/metabolismo , Hiperplasia Suprarrenal Congênita/sangue , Relação Dose-Resposta a Droga , Deficiência Intelectual/diagnóstico , Anti-Inflamatórios/farmacologia , Testes Neuropsicológicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA